Canada markets close in 2 hours 26 minutes

Biomark Diagnostics Inc (20B.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
0.1910+0.0060 (+3.24%)
As of 12:06PM CEST. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-03-31
2022-03-31
2021-03-31
Total Revenue
163.161
153.492
43.933
0
Operating Expenses
Research Development
704.293
545.841
497.773
118.432
Selling General and Administrative
721.415
958.959
564.508
868.527
Total Operating Expenses
1,802
1,886
1,447
1,083
Operating Income or Loss
-1,638
-1,732
-1,403
-1,083
Interest Expense
96.95
110.232
49.683
4.138
Total Other Income/Expenses Net
-
-
-1.114
-7.467
Income Before Tax
-1,538
-1,842
-1,454
-1,094
Income from Continuing Operations
-1,538
-1,842
-1,454
-1,094
Net Income
-1,538
-1,842
-1,454
-1,094
Net Income available to common shareholders
-1,538
-1,842
-1,454
-1,094
Basic EPS
-0.02
-0.02
-0.02
-0.02
Diluted EPS
-0.02
-0.02
-0.02
-0.02
Basic Average Shares
74,339
82,778
77,929
73,305
Diluted Average Shares
74,339
82,778
77,929
73,305